Maybe something here for you TTE,
Market opportunities
The company states that GvHD has an estimated market opportunity of US$0.3 billion,
CLI has an estimated market opportunity of US$1.4 billion
and OA has an estimated market opportunity of US$11.6 billion.
Consequentially, interest from major pharmaceutical companies in these areas of cell therapeutics is increasing.
Macdonald said this was one of the reasons Cynata recently knocked back a takeover bid which it believed undervalued the company.
He said: “Last year the company received takeover bids, one of which was disclosed to the market at $2 per share.
“Ultimately, we decided not to go ahead with that, but it’s a nice position to be in when a global, major pharmaceutical company decides that the technology looks exciting enough that they’re prepared to pay a couple of hundred million dollars for it.
“That was also important validation of our technology and our strategy.”
Maybe something here for you TTE, Market opportunitiesThe...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.0¢ | 24.5¢ | $19.72K | 78.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31298 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 39430 | 1 |
View Market Depth
| Last trade - 15.59pm 09/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |